UK's regulatory and legislative double standards in the treatment of psychedelics and drugs for assisted suicide

This editorial by Ruslan Zinchenko examines the UK's inconsistent regulatory approach towards psychedelics and drugs intended for assisted suicide. The author questions why assisted suicide drugs can circumvent standard regulations despite limited evidence, while psychedelics, which show promising international results, face substantial barriers. Zinchenko argues for equal regulatory standards for both categories to facilitate clinical research and ensure patient safety.